Lista de obras -

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

artículo científico publicado en 2016

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

scientific article published on 24 June 2020

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.

artículo científico publicado en 2006

Adenoviral strategies for the gene therapy of cancer

artículo científico publicado en 2005

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study

artículo científico publicado en 2016

Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice

artículo científico publicado en 2010

Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? ⬇️

artículo científico publicado el 16 de noviembre de 2011

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels

artículo científico publicado en 2016

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

artículo científico publicado en 2016

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

scientific article published in Nature Communications

Basaloid carcinoma of the prostate: A literature review with case report

artículo científico publicado en 2012

Blood lipids and prostate cancer: a Mendelian randomization analysis

artículo científico publicado en 2016

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

artículo científico publicado en 2011

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

artículo científico publicado en 2016

Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients

artículo científico publicado en 2012

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses ⬇️

artículo científico publicado en 2015

Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus ⬇️

artículo científico publicado en 2014

Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy

artículo científico publicado en 2015

Differential effects of Paclitaxel on dendritic cell function ⬇️

artículo científico publicado en 2010

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 ⬇️

artículo científico publicado el 5 de junio de 2011

Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer

artículo científico publicado en 2018

Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer

artículo científico publicado en 2011

Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy

artículo científico publicado en 2008

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo ⬇️

artículo científico publicado el 13 de septiembre de 2010

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse

artículo científico publicado en 2013

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

artículo científico publicado en 2016

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

artículo científico publicado en 2016

Genome-wide association study of prostate cancer-specific survival

artículo científico publicado en 2015

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

artículo científico publicado en 2018

HOX genes in ovarian cancer

artículo científico publicado en 2011

HOX transcription factors are potential targets and markers in malignant mesothelioma

artículo científico publicado en 2015

Immunotherapeutic potential of whole tumour cells.

artículo científico publicado en 2002

Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization

artículo científico publicado en 2011

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis

artículo científico publicado en 2016

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response

artículo científico publicado en 2020

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

artículo científico publicado en 2015

Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents

artículo científico publicado en 2014

Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. ⬇️

artículo científico publicado en 2018

Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus: Using a Bladder Tumor Precision-Cut Slice Model System to Assess Viral Efficacy

artículo científico publicado en 2020

Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21.

artículo científico publicado en 2015

Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

scientific article published on 04 July 2019

Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors

artículo científico publicado en 2014

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

artículo científico publicado en 2018

Prediction of individual genetic risk to prostate cancer using a polygenic score

artículo científico publicado en 2015

Prostate cancer vaccines.

artículo científico publicado en 2013

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

artículo científico publicado en 2016

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy

artículo científico publicado en 2008

Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study

artículo científico publicado en 2020

Recent developments and current status of gene therapy using viral vectors in the United Kingdom

artículo científico publicado en 2004

Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies

artículo científico publicado en 2003

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway ⬇️

artículo científico publicado en 2012

Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia

artículo científico publicado en 2012

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma

artículo científico publicado en 2009

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

artículo científico publicado en 2011

Targeting HOX and PBX transcription factors in ovarian cancer

artículo científico publicado en 2010

Targeting HOX transcription factors in prostate cancer

artículo científico publicado en 2014

The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis

artículo científico publicado en 2010

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.

artículo científico publicado en 2013

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium

artículo científico publicado en 2015

The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site

artículo científico publicado en 2014

Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.

artículo científico publicado en 2010

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

artículo científico publicado en 2021

Tumor antigens as surrogate markers and targets for therapy and vaccines

artículo científico publicado en 2007

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers

artículo científico publicado en 2010

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma

artículo científico publicado en 2012

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.

Adenoviral strategies for the gene therapy of cancer

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study

Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice

Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? ⬇️

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

Basaloid carcinoma of the prostate: A literature review with case report

Blood lipids and prostate cancer: a Mendelian randomization analysis

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses ⬇️

Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus ⬇️

Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy

Differential effects of Paclitaxel on dendritic cell function ⬇️

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 ⬇️

Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer

Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer

Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo ⬇️

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

Genome-wide association study of prostate cancer-specific survival

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

HOX genes in ovarian cancer

HOX transcription factors are potential targets and markers in malignant mesothelioma

Immunotherapeutic potential of whole tumour cells.

Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents

Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. ⬇️

Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus: Using a Bladder Tumor Precision-Cut Slice Model System to Assess Viral Efficacy

Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21.

Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

Prediction of individual genetic risk to prostate cancer using a polygenic score

Prostate cancer vaccines.

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy

Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study

Recent developments and current status of gene therapy using viral vectors in the United Kingdom

Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway ⬇️

Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia

Shared heritability and functional enrichment across six solid cancers

Shared heritability and functional enrichment across six solid cancers

Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

Targeting HOX and PBX transcription factors in ovarian cancer

Targeting HOX transcription factors in prostate cancer

The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium

The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site

Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Tumor antigens as surrogate markers and targets for therapy and vaccines

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma